Articles that mention Valeant Pharmaceuticals -BoardProspects

Valeant Pharmaceuticals

0 Comments Leave a Comment

1-15 of 29 1 2 »
1. Mentioned In 29 Articles
2. Is This the End of Activist Investing?
  
  Explore FoxBusiness.com Apr 6 2018 BoardBlogs
  
  ...lar rate this year, one source told the WSJ. Ackman has recently made a few bad bets, including Herbalife and Valeant Pharmaceuticals. But while Pershing Square is reportedly seeing investors cash out, overall shareholde...
  Read Full Article
  
  Comment
  
  Mentions: Activist Investors Management Investors
3. Has Bill Ackman Lost His Touch? Pershing Investors Say Yes
  
  Explore Fool.com Apr 5 2018 BoardBlogs
  
  ...et earlier this year. Ackman has also made missteps on the bullish side of the spectrum. His calls supporting Valeant Pharmaceuticals International led to massive investments from Pershing Square in the controversial pha...
  Read Full Article
  
  Comment
  
  Mentions: Activist Investors Management Investors
4. Three Activist Hedge Funds to Watch
  
  Explore Stock Market Today Jan 23 2018 BoardBlogs
  
  ... Oplink Communications, Obagi Medical Products Inc., and Solta Medical Inc. Solta and Obagi were both sold to Valeant Pharmaceuticals International Inc. for significant premiums, helping drive Voce's returns. Land & Buil...
  Read Full Article
  
  Comment
  
  Mentions: Investment Management CEO
5. Jeffrey Ubben Joins AES Board of Directors
  
  Explore businesswire.com Jan 18 2018 BoardMoves
  
  ...of Twenty-First Century Fox Inc., and is a former Director of Gartner Group, Inc., Misys plc, Sara Lee Corp., Valeant Pharmaceuticals International and Willis Towers Watson plc, as well as other public and private compan...
  Read Full Article
  
  Comment
  
  Mentions: Management Audit Committee SEC
6. Valeant CEO Papa says Drugmaker has 'Turnaround Opportunity of a Lifetime'
  
  Explore bnn.ca Jan 10 2018 BoardNews
  
  ...d during a presentation Wednesday at the J.P. Morgan Healthcare Conference in San Francisco... (Bloomberg) -- Valeant Pharmaceuticals International Inc. became a household name with its historic rise and fall. Reviving t...
  Read Full Article
  
  Comment
  
  Mentions: Conference CEO Bill Ackman
7. Pershing Square, Valeant asked to appear for hearing on insider trading suit (VRX, Agn)
  
  Explore Stock Market Data Today Jan 3 2018 BoardNews
  
  ...iscuss the proposed settlement in an insider trading lawsuit. Jan 2 (Reuters) - A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a ...
  Read Full Article
  
  Comment
  
  Mentions: Management Bill Ackman lawsuit
8. Top Canadian CEOs made more than 200 times average worker — study
  
  Explore Jamaica Observer Jan 3 2018 BoardNews
  
  ... highest paid among them were raking in record-breaking earnings,” said the report's author, David Macdonald. Valeant Pharmaceuticals' CEO Joseph Papa was the best paid in 2016, making Can$83.1 million in eight months on...
  Read Full Article
  
  Comment
  
  Mentions: CEO crisis Valeant Pharmaceuticals
9. Pershing Square, Valeant Arrive at Settlement Split for Allergan Lawsuit
  
  Explore reuters.com Dec 30 2017 BoardNews
  
  ...before bidding for Allergan Plc ... (Reuters) - Activist investor William Ackman’s Pershing Square PHS.AS and Valeant Pharmaceuticals (VRX.TO) on Friday decided to pay $290 million to settle a lawsuit that accused them o...
  Read Full Article
  
  Comment
  
  Mentions: Management CEO Bill Ackman
10. Bill Ackman Just \Took a $200 Million Hit to His Reputation
  
  Explore Business Insider Dec 29 2017 BoardNews
  
  $Bill Ackman Just \Took a $200 Million Hit to His Reputation$
  ...ettlement has been reached in the insider trading case against Bill Ackman's hedge fund, Pershing Square, and Valeant Pharmaceuticals. "Pershing Square and Valeant have agreed to split the $290 million total settlement s...
  Read Full Article
  
  Comment
  
  Mentions: CEO hostile takeover Bill Ackman
11. Judge Sides Against Ackman and Valeant in Preliminary Allergan Ruling
  
  Explore wsj.com Dec 22 2017 BoardNews
  
  ... to agree to any deal... A preliminary ruling from a federal judge against William Ackman, his hedge fund and Valeant Pharmaceuticals International Inc. in an insider-trading case could trigger a settlement between the a...
  Read Full Article
  
  Comment
  
  Mentions: Hedge Fund Bill Ackman Valeant Pharmaceuticals
12. Bill Ackman Likely to Face Trial on Allergan Insider-Trading Claims
  
  Explore Bloomberg Dec 8 2017 BoardNews
  
  ...S. District Judge David Carter issued a tentative ruling at a hearing Friday, denying a request by Ackman and Valeant Pharmaceuticals International Inc. to throw out the allegations by Allergan shareholders. They claim t...
  Read Full Article
  
  Comment
  
  Mentions: Management CEO Takeover Bid
13. Broadcom's Boardroom Battle With Qualcomm Will Likely Lead to a Higher Bid
  
  Explore Stock Market Today Dec 4 2017 BoardBlogs
  
  ...ght acquirer, which may be considered friendlier and willing to pay more than Broadcom. For example, in 2014, Valeant Pharmaceuticals International Inc. joined forces with Bill Ackman's Pershing Square to employ a boardr...
  Read Full Article
  
  Comment
  
  Mentions: Technology Delaware Bill Ackman
14. A Broadcom Director Fight Could Be Next at Qualcomm
  
  Explore Stock Market Today Nov 13 2017 BoardBlogs
  
  ...pproach with its ultimately successful sweetened $52 billion hostile takeover of Anheuser Busch. And in 2014, Valeant Pharmaceuticals International joined forces with Bill Ackman's Pershing Square to employ a boardroom e...
  Read Full Article
  
  Comment
  
  Mentions: Technology Management hostile takeover
15. Bill Ackman Overwhelmingly Loses ADP Battle in Latest Blow to Activist Investor
  
  Explore Stock Market Today Nov 7 2017 BoardNews
  
  ...ow to Ackman who has experienced a rough couple of years. Ackman has had serious troubles with investments in Valeant Pharmaceuticals International Inc. (VRX) , Chipotle Mexican Grill Inc. (CMG) and a large short positio...
  Read Full Article
  
  Comment
  
  Mentions: Management CEO Bill Ackman
16. We May be About to Witness the Fall of Wall Street God
  
  Explore Business Insider Nov 7 2017 BoardNews
  
  ...old on to ADP win or lose. That's another Ackman flaw at play. As an investor, he has a hard time letting go. Valeant Pharmaceuticals comes to mind. After massive fraud at the company was revealed in October of 2015, Ack...
  Read Full Article
  
  Comment
  
  Mentions: Activist Investors Investors CEO
17. 1-15 of 29 1 2 »